On January 26, 2023, the U.S. Food & Drug Administration’s Vaccines and Related Biological Products Advisory Committee met. The recording of the meeting and meeting materials are available for viewing at https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-january-26-2023-meeting-announcement.
The committee met in open session to discuss the original COVID-19 vaccine; COVID-19 vaccine bivalent effectiveness and safety; and future vaccination regimens addressing COVID-19.
